Hai-Lang He (Hailang He)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Advanced Non Small Cell Lung Cancer

Chemotherapy Induced

Epidermal Growth Factor Receptor

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Nanjing University of Chinese Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Nanjing University of Chinese Medicine Sep 01 2011 - Jun 30 2014

China

MSC

Publications

Wenpan Peng, Yong Xu, Fanchao Feng, Cheng Gu, Zhichao Wang, Di Han, Xian-Mei Zhou, Hai-Lang He
Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Zhichao Wang, Fanchao Feng, Qi Wu, Yihan Jin, Cheng Gu, Yong Xu, Xian-Mei Zhou, Hai-Lang He
Disodium Cantharidinate and Vitamin B6 Injection Adjunct with Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Ailing Cao, Hai-Lang He, Mengxin Jing, Beibei Yu, Xian-Mei Zhou
Shenfu Injection Adjunct with Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review. Evidence-based complementary and alternative medicine : eCAM 2017 (2017)
Hai-Lang He, Dan Wang, Jie Tang, Xian-Mei Zhou, Jian-Xin Li, Ling Xu
Jin Fu Kang Oral Liquid Inhibits Lymphatic Endothelial Cells Formation and Migration. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)